English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 45422/58598 (78%)
造訪人次 : 2519550      線上人數 : 202
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    請使用永久網址來引用或連結此文件: http://libir.tmu.edu.tw/handle/987654321/58097


    題名: 利用二維高效液相層析儀同時分離乳酸與3-羥基丁酸鏡像異構物
    Development of a two-dimensional HPLC system for the simultaneous determination of lactate and 3-hydroxybutyrate enantiomers
    作者: 劉書伶
    Liu, Shu-Ling
    貢獻者: 許秀蘊
    李仁愛
    關鍵詞: 乳酸;3-羥基丁酸;鏡像異構物分離;高效液相層析儀
    Chiral separation;2D-HPLC;Lactic acid;3-Hydroxybutyric acid
    日期: 2014-06-23
    上傳時間: 2019-09-24 12:58:39 (UTC+8)
    摘要: 此篇論文主在建立以二維液相層析儀同時分離乳酸 (Lactate)與3-羥基丁酸 (3-Hydroxybutyrate)鏡像異構物。將螢光衍生化試劑
    4-(N-Chloroformylmethyl-N-methylamino)-7-nitro-2,1,3-benzoxadiazole (NBD-COCl)加入含有乳酸以及 3-羥基丁酸的溶液,將混合液置於60˚C 下加熱 15 分鐘,進行螢光衍生化反應後取 20 μL 注入液相層析
    儀。在第一維的液相層析儀中,利用 capillary monolithic ODS 管柱可以成功分離乳酸與 3-羥基丁酸。在第二維的液相層析儀中利用QD-AX、KSAACSP-001S 管柱及不同比例之氰甲烷、甲醇與三氟乙酸所組成的移動相,來進行乳酸與 3-羥基丁酸鏡像異構物的分離。所得之最佳分離係數分別是 1.14 與 1.08,偵測極限(LOD)大約為 2 微毫莫爾 (2 fmol/inj)。利用此方法成功定量了生物檢體,如在健康人的血漿、尿液以及唾液中發現,無論是乳酸或是 3-羥基丁酸的鏡像異構物均存在人體中。未來此方法可望應用在釐清乳酸與 3-羥基丁酸的鏡像異構物與疾病之間的關聯性與其個別的生理意義。
    A two-dimensional HPLC system has been established for the
    simultaneous determination of lactate and 3-hydroxybutyrate enantiomers. Lactate and 3-hydroxybutyrate were derivatized with NBD-COCl, and heated at 60˚C for 15 min. In the first dimension, the lactate and 3-hydroxybutyrate were separated by a capillary monolithic ODS column. In the second dimension, various chiral stationary phases had been tested.
    The lactate enantiomers can be separated by the QD-AX and the 3-hydroxybutyrate enantiomers can be separated by the KSAASCP-001S. The mobile phases were composed of acetonitrile, methanol and TFA. The separation factors are 1.14 and 1.08 respectively. The detection limit of lactate and 3-hydroxybutyrate are 2 fmol/injection. Now by using the 2D-HPLC system, we can separate lactate and 3-hydroxybutyrate enantiomers at the same time. We also examined this method in the clinical healthy human samples, and we can find that both the lactate and 3-hydroxybutyrate enantiomers exist on healthy human serum, urine and saliva.
    In the end, we hope this method can be applied to various clinical disease samples and that will help us to clarify the role of these enantiomers.
    描述: 碩士
    指導教授-許秀蘊
    共同指導教授-李仁愛
    委員-方嘉佑
    委員-蔡東湖
    委員-李宗徽
    資料類型: thesis
    顯示於類別:[藥學系] 博碩士論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    index.html0KbHTML117檢視/開啟


    在TMUIR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    著作權聲明 Copyright Notice
    • 本平台之數位內容為臺北醫學大學所收錄之機構典藏,包含體系內各式學術著作及學術產出。秉持開放取用的精神,提供使用者進行資料檢索、下載與取用,惟仍請適度、合理地於合法範圍內使用本平台之內容,以尊重著作權人之權益。商業上之利用,請先取得著作權人之授權。

      The digital content on this platform is part of the Taipei Medical University Institutional Repository, featuring various academic works and outputs from the institution. It offers free access to academic research and public education for non-commercial use. Please use the content appropriately and within legal boundaries to respect copyright owners' rights. For commercial use, please obtain prior authorization from the copyright owner.

    • 瀏覽或使用本平台,視同使用者已完全接受並瞭解聲明中所有規範、中華民國相關法規、一切國際網路規定及使用慣例,並不得為任何不法目的使用TMUIR。

      By utilising the platform, users are deemed to have fully accepted and understood all the regulations set out in the statement, relevant laws of the Republic of China, all international internet regulations, and usage conventions. Furthermore, users must not use TMUIR for any illegal purposes.

    • 本平台盡力防止侵害著作權人之權益。若發現本平台之數位內容有侵害著作權人權益情事者,煩請權利人通知本平台維護人員([email protected]),將立即採取移除該數位著作等補救措施。

      TMUIR is made to protect the interests of copyright owners. If you believe that any material on the website infringes copyright, please contact our staff([email protected]). We will remove the work from the repository.

    Back to Top
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋